Works matching IS 13419625 AND DT 2017 AND VI 22 AND IP 1


Results: 24
    1

    Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 88, doi. 10.1007/s10147-016-1022-9
    By:
    • Takemoto, Hiroyoshi;
    • Nishimura, Junichi;
    • Komori, Takamichi;
    • Kim, Ho;
    • Ota, Hirofumi;
    • Suzuki, Rei;
    • Ikenaga, Masakazu;
    • Ikeda, Masataka;
    • Yamamoto, Hirofumi;
    • Satoh, Taroh;
    • Hata, Taishi;
    • Takemasa, Ichiro;
    • Mizushima, Tsunekazu;
    • Doki, Yuichirou;
    • Mori, Masaki
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 80, doi. 10.1007/s10147-016-1028-3
    By:
    • Kitano, Yuki;
    • Iwatsuki, Masaaki;
    • Kurashige, Junji;
    • Kuroda, Daisuke;
    • Kosumi, Keisuke;
    • Baba, Yoshifumi;
    • Sakamoto, Yasuo;
    • Miyamoto, Yuji;
    • Yoshida, Naoya;
    • Haga, Yoshio;
    • Baba, Hideo
    Publication type:
    Article
    8

    The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 159, doi. 10.1007/s10147-016-1029-2
    By:
    • Murasawa, Hiromi;
    • Koie, Takuya;
    • Ohyama, Chikara;
    • Yamamoto, Hayato;
    • Imai, Atsushi;
    • Hatakeyama, Shingo;
    • Yoneyama, Takahiro;
    • Hashimoto, Yasuhiro;
    • Iwabuchi, Ikuya;
    • Ogasawara, Masaru;
    • Kawaguchi, Toshiaki
    Publication type:
    Article
    9
    10
    11

    A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 166, doi. 10.1007/s10147-016-1037-2
    By:
    • Kamba, Tomomi;
    • Kamoto, Toshiyuki;
    • Maruo, Shinichiro;
    • Kikuchi, Takashi;
    • Shimizu, Yosuke;
    • Namiki, Shunichi;
    • Fujimoto, Kiyohide;
    • Kawanishi, Hiroaki;
    • Sato, Fuminori;
    • Narita, Shintaro;
    • Satoh, Takefumi;
    • Saito, Hideo;
    • Sugimoto, Mikio;
    • Teishima, Jun;
    • Masumori, Naoya;
    • Egawa, Shin;
    • Sakai, Hideki;
    • Okada, Yusaku;
    • Terachi, Toshiro;
    • Ogawa, Osamu
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
    By:
    • Yamamoto, Noboru;
    • Goto, Koichi;
    • Nishio, Makoto;
    • Chikamori, Kenichi;
    • Hida, Toyoaki;
    • Maemondo, Makoto;
    • Katakami, Nobuyuki;
    • Kozuki, Toshiyuki;
    • Yoshioka, Hiroshige;
    • Seto, Takashi;
    • Tajima, Kosei;
    • Tamura, Tomohide
    Publication type:
    Article
    19
    20
    21
    22
    23
    24